Coffee Consumption for Intestinal Function Recovery After Laparoscopic Gynecologic Surgery
1 other identifier
interventional
100
1 country
2
Brief Summary
Minimally invasive surgery (MIS) has revolutionized women's healthcare. Laparoscopy is an excellent route of MIS. Today, laparoscopic surgery is one of the major procedure in the management of a gynecologic disease. It has revealed benefits of decreased morbidity, earlier discharged, and quicker return to normal daily activities, and shorter hospital when compared to abdominal approach. Postoperative ileus (POI) defined as an uncomplicated ileus occurring following surgery, resolving spontaneously within 2 to 3 days. Clinically, it is characterized by abdominal distension, a lack of bowel sounds, nausea, vomiting, stomach cramps, and lack of flatus. It leads to morbidity and delays in patient discharge from the hospital, leading to an increased economic burden on the healthcare system. That's why many researchers have focused on the prevent of postoperative ileus; many studies have investigated preventive approaches such as early mobilization of the patient, adequate pain control, epidural anaesthesia, hot pack therapy, motility agents such as metoclopramide, and alvimopan. Although POI incidence has lower after the laparoscopic surgery it remains a major problem during the postoperative period. Recent studies demonstrated that coffee consumption is associated with improved gastrointestinal function without worsening of postoperative morbidity for both open and laparoscopic surgery. However, until now, no studies investigating the effect of postoperative coffee consumption at laparoscopic gynecologic surgery. Therefore, the investigators performed a randomized controlled trial to assess whether coffee consumption accelerates the recovery of bowel function after laparoscopic gynecologic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2019
CompletedFirst Posted
Study publicly available on registry
May 24, 2019
CompletedStudy Start
First participant enrolled
May 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedMarch 27, 2020
March 1, 2020
7 months
May 19, 2019
March 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Time to first passage of flatus
Patients were checked hourly by auscultation for bowel sounds and were asked to note the time of first flatus and defecation and to inform the observing nurses or assistant.The time to the first passage of flatus after surgery during routine postoperative care.
72 hours
Secondary Outcomes (2)
Time to tolerance of a solid diet
72 hours
Time to the first bowel movement
72 hours
Study Arms (2)
control group
NO INTERVENTIONthe control group received 3 cups hot water on the 6th, 12th and 18th hours after the operation
study group
EXPERIMENTALdrank 3 cups of caffeinated coffee on the 6th, 12th and 18th hours after the operation.
Interventions
All patients were asked to drink the entire 150-mL amounts within 20 minutes under the supervision of a nurse or doctor. Patients were free to drink any amount of water but no more coffee, black tea, or other forms of caffeine, such as soda. Coffee and hot water were prepared with a conventional coffee machine (Nescafe Alegria; 100 g caffeine; Nestlé. Gatwick, United Kingdom).
Eligibility Criteria
You may qualify if:
- Patients underwent total laparoscopic hysterectomy with or without additional surgery \*salpingo-oophorectomy,
- salpingectomy,
- pelvic and/or para-aortic lymphadenectomy
You may not qualify if:
- patients with hypersensitivity or allergy to caffeine/ coffee,
- patients with thyroid disease,
- patients with inflammatory bowel disease,
- patients with compromised liver function,
- patients with clinically significant cardiac arrhythmia,
- patients with chronic constipation (defined as \< 2 bowel movements per week),
- patients with a history of abdominal bowel surgery,
- patients with previous abdominal irradiation,
- the requirement for postoperative care in the intensive care unit \>24 hours postoperatively,
- the requirement for nasogastric tube drainage beyond the end of the surgery
- requirement bowel anastomosis
- conversion to laparotomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Kemal Gungorduk
Muğla, 35460, Turkey (Türkiye)
Mugla Sıtkı Kocman University Education and Research Hospital
Muğla, 48000, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 19, 2019
First Posted
May 24, 2019
Study Start
May 27, 2019
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
March 27, 2020
Record last verified: 2020-03